146 related articles for article (PubMed ID: 23864426)
1. Investigation into the feasibility of thioditaloside as a novel scaffold for galectin-3-specific inhibitors.
Bum-Erdene K; Gagarinov IA; Collins PM; Winger M; Pearson AG; Wilson JC; Leffler H; Nilsson UJ; Grice ID; Blanchard H
Chembiochem; 2013 Jul; 14(11):1331-42. PubMed ID: 23864426
[TBL] [Abstract][Full Text] [Related]
2. Taloside inhibitors of galectin-1 and galectin-3.
Collins PM; Oberg CT; Leffler H; Nilsson UJ; Blanchard H
Chem Biol Drug Des; 2012 Mar; 79(3):339-46. PubMed ID: 22136701
[TBL] [Abstract][Full Text] [Related]
3. Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model.
Stannard KA; Collins PM; Ito K; Sullivan EM; Scott SA; Gabutero E; Darren Grice I; Low P; Nilsson UJ; Leffler H; Blanchard H; Ralph SJ
Cancer Lett; 2010 Dec; 299(2):95-110. PubMed ID: 20826047
[TBL] [Abstract][Full Text] [Related]
4. 1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.
Salameh BA; Cumpstey I; Sundin A; Leffler H; Nilsson UJ
Bioorg Med Chem; 2010 Jul; 18(14):5367-78. PubMed ID: 20538469
[TBL] [Abstract][Full Text] [Related]
5. Lactulose as a novel template for anticancer drug development targeting galectins.
Kishor C; Ross RL; Blanchard H
Chem Biol Drug Des; 2018 Oct; 92(4):1801-1808. PubMed ID: 29888844
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Structure-Activity Relationships, and In Vivo Evaluation of Novel Tetrahydropyran-Based Thiodisaccharide Mimics as Galectin-3 Inhibitors.
Xu L; Hartz RA; Beno BR; Ghosh K; Shukla JK; Kumar A; Patel D; Kalidindi N; Lemos N; Gautam SS; Kumar A; Ellsworth BA; Shah D; Sale H; Cheng D; Regueiro-Ren A
J Med Chem; 2021 May; 64(10):6634-6655. PubMed ID: 33988358
[TBL] [Abstract][Full Text] [Related]
7. Thiodigalactoside-Bovine Serum Albumin Conjugates as High-Potency Inhibitors of Galectin-3: An Outstanding Example of Multivalent Presentation of Small Molecule Inhibitors.
Zhang H; Laaf D; Elling L; Pieters RJ
Bioconjug Chem; 2018 Apr; 29(4):1266-1275. PubMed ID: 29474087
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of new thiodigalactoside-based chemical probes to label galectin-3.
van Scherpenzeel M; Moret EE; Ballell L; Liskamp RM; Nilsson UJ; Leffler H; Pieters RJ
Chembiochem; 2009 Jul; 10(10):1724-33. PubMed ID: 19492387
[TBL] [Abstract][Full Text] [Related]
9. Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity.
Peterson K; Kumar R; Stenström O; Verma P; Verma PR; Håkansson M; Kahl-Knutsson B; Zetterberg F; Leffler H; Akke M; Logan DT; Nilsson UJ
J Med Chem; 2018 Feb; 61(3):1164-1175. PubMed ID: 29284090
[TBL] [Abstract][Full Text] [Related]
10. Screening for galectin-3 inhibitors from synthetic lacto-N-biose libraries using microscale affinity chromatography coupled to mass spectrometry.
Fort S; Kim HS; Hindsgaul O
J Org Chem; 2006 Sep; 71(19):7146-54. PubMed ID: 16958507
[TBL] [Abstract][Full Text] [Related]
11. A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model.
Rajput VK; MacKinnon A; Mandal S; Collins P; Blanchard H; Leffler H; Sethi T; Schambye H; Mukhopadhyay B; Nilsson UJ
J Med Chem; 2016 Sep; 59(17):8141-7. PubMed ID: 27500311
[TBL] [Abstract][Full Text] [Related]
12. C2-symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3: efficient lectin inhibition through double arginine-arene interactions.
Cumpstey I; Sundin A; Leffler H; Nilsson UJ
Angew Chem Int Ed Engl; 2005 Aug; 44(32):5110-2. PubMed ID: 16007713
[No Abstract] [Full Text] [Related]
13. Molecular Recognition of a Thomsen-Friedenreich Antigen Mimetic Targeting Human Galectin-3.
Santarsia S; Grosso AS; Trovão F; Jiménez-Barbero J; Carvalho AL; Nativi C; Marcelo F
ChemMedChem; 2018 Oct; 13(19):2030-2036. PubMed ID: 30094951
[TBL] [Abstract][Full Text] [Related]
14. Elucidation of Hydrogen Bonding Patterns in Ligand-Free, Lactose- and Glycerol-Bound Galectin-3C by Neutron Crystallography to Guide Drug Design.
Manzoni F; Wallerstein J; Schrader TE; Ostermann A; Coates L; Akke M; Blakeley MP; Oksanen E; Logan DT
J Med Chem; 2018 May; 61(10):4412-4420. PubMed ID: 29672051
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamics of bovine spleen galectin-1 binding to disaccharides: correlation with structure and its effect on oligomerization at the denaturation temperature.
Schwarz FP; Ahmed H; Bianchet MA; Amzel LM; Vasta GR
Biochemistry; 1998 Apr; 37(17):5867-77. PubMed ID: 9558320
[TBL] [Abstract][Full Text] [Related]
16. Structures of the Erythrina corallodendron lectin and of its complexes with mono- and disaccharides.
Elgavish S; Shaanan B
J Mol Biol; 1998 Apr; 277(4):917-32. PubMed ID: 9545381
[TBL] [Abstract][Full Text] [Related]
17. Structural and thermodynamic studies on cation-Pi interactions in lectin-ligand complexes: high-affinity galectin-3 inhibitors through fine-tuning of an arginine-arene interaction.
Sörme P; Arnoux P; Kahl-Knutsson B; Leffler H; Rini JM; Nilsson UJ
J Am Chem Soc; 2005 Feb; 127(6):1737-43. PubMed ID: 15701008
[TBL] [Abstract][Full Text] [Related]
18. Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1.
van Hattum H; Branderhorst HM; Moret EE; Nilsson UJ; Leffler H; Pieters RJ
J Med Chem; 2013 Feb; 56(3):1350-4. PubMed ID: 23281927
[TBL] [Abstract][Full Text] [Related]
19. Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8.
Oberg CT; Blanchard H; Leffler H; Nilsson UJ
Bioorg Med Chem Lett; 2008 Jul; 18(13):3691-4. PubMed ID: 18539029
[TBL] [Abstract][Full Text] [Related]
20. Binding free energy calculations of galectin-3-ligand interactions.
Mandal TK; Mukhopadhyay C
Protein Eng; 2002 Dec; 15(12):979-86. PubMed ID: 12601137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
